The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Open accessAbstract
AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the largest multicentre study to date (>3600 patients with HCM), syncope was an independent predictor of the composite of SCD and ICD discharge (hazard ratio 2.05, 95% CI 1.48-2.82). 350”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LVOT obstruction has been identified as a predictor of sudden death in some but not all studies”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“initially validated in 2013.”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citationPeduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Research works printed but not linked: 1
- 2012, Circulation: Arrhythmia and Electrophysiology, 6, 443
Cited by
Sorted by citations
Items 701–800 of 999
Akita, K., Suwa, K., Ohno, K., Weiner, S. D., Tower-Rader, A. F., Fifer, M. A., Maekawa, Y., & Shimada, Y. J. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132911 · Cited by 5
A Practical Approach to Multimodality Imaging in Hypertrophic Cardiomyopathy
Dalsania, A. K., Park, C. M., Nagraj, S., Lorenzatti, D., Filtz, A., Weissler‐Snir, A., Garcia, M. J., Slipczuk, L. N., & Schenone, A. L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082606 · Cited by 4
Villa, R. B., Escobar-López, L., Larena, D. V., Salazar‐Mendiguchía, J., Echeto, A., Hernández, I., Rebollo-Gómez, E., & Gimeno, J. R. (2025) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2025.04.004 · Cited by 4
Self-citationWatkinson, O. T., & Elliot, P. M. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.07.724 · Cited by 4
Kommentar zu den 2014 ESC-Guidelines zur Diagnostik und Therapie der hypertrophen Kardiomyopathie
Frey, N., Pieske, B. M., Steven, D., Tillmanns, C., & Baldus, S. E. (2016) · Der Kardiologe · doi:10.1007/s12181-016-0044-x · Cited by 4
Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study
Zhu, A., Bews, H. J., Cheung, D. Y. C., Nagalingam, R. S., Mittal, I., Goyal, V., Asselin, C. Y., Kirkpatrick, I. D. C., Czubryt, M. P., & Jassal, D. S. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0636 · Cited by 4
A Rare Case of Mass-Like Hypertrophic Cardiomyopathy
Shuroog, J., Canakis, J. P., Khan, F. J., Suryanarayana, P. G., & Soherwardi, S. (2021) · Cureus · doi:10.7759/cureus.12787 · Cited by 4
Future bradyarrhythmia in patients with hypertrophic cardiomyopathy
Nakasuka, K., Kitada, S., Kawada, Y., Kato, M., Kikuchi, S., Seo, Y., & Ohte, N. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100735 · Cited by 4
Chakraborty, P., Suszko, A. M., Viswanathan, K., Sheikholeslami, K., Spears, D., Adler, A., Woo, A., Rakowski, H., & Chauhan, V. S. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022036 · Cited by 4
Batzner, A., & Seggewiß, H. (2020) · Herz · doi:10.1007/s00059-020-04899-y · Cited by 4
Malcolmson, J. W., Hughes, R. K., Joshi, A., Cooper, J. A., Breitenstein, A., Ginks, M., Petersen, S. E., MOHIDDIN, S. A., & Dhinoja, M. (2022) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447221108816 · Cited by 4
Assaf, A., Theuns, D. A. M. J., Michels, M., Roos‐Hesselink, J. W., Szili‐Törok, T., & Yap, S. (2023) · Expert Review of Medical Devices · doi:10.1080/17434440.2023.2171862 · Cited by 4
Inherited cardiomyopathies: how nurses can facilitate holistic care for patients and their families
Martin, L., Mason, S., Kirkby, C., Kearl, F., Hargrave, J., Partridge, J., Taylor, J. S., Bueser, T. ‘., & Cowley, B. (2023) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2022.0107 · Cited by 4
Zhou, K., Xiang, J., Li, G.-Y., Pu, X., & Zhang, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.988274 · Cited by 4
Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan
Samarraie, A. A., Petzl, A. M., Cadrin‐Tourigny, J., & Tadros, R. (2023) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2023.04.010 · Cited by 4
Ya, H., & Zhou, J. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.10.056 · Cited by 4
Müller, M., Reeve, H. W. J., Cannings, T. I., & Samworth, R. J. (2024) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1093/jrsssb/qkae083 · Cited by 11
ICD-Therapie zur Primärprävention des plötzlichen Herztodes
Neuzner, J., & Gradaus, R. (2015) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-015-0371-9 · Cited by 4
Indikationen für implantierbare Loop-Rekorder bei Kanalopathien und ventrikulären Tachykardien
Köbe, J., Wasmer, K., Reinke, F., & Eckardt, L. (2016) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-016-0474-y · Cited by 4
Özyılmaz, S. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2018.15945 · Cited by 4
Risk stratification in childhood hypertrophic cardiomyopathy
Norrish, G., & Kaski, J. P. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.24 · Cited by 4
O’Donovan, C. E., Skinner, J. R., & Broadbent, E. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.07.008 · Cited by 4
Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts
Brough, J. J., Jain, M., Serrano, T. J., Kruszka, P. S., & McGuffey, E. J. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31772 · Cited by 4
Thirty Controversies and Considerations in Hypertrophic Cardiomyopathy
Masri, A., Nazer, B., Al‐Rashdan, L., Mannello, M., Fischer, K. L., Akhavein, R., Divanji, P., Song, H. K., & Heitner, S. B. (2020) · Structural Heart · doi:10.1080/24748706.2020.1844926 · Cited by 4
Hayashi, H., Iwasaki, Y., Arai, T., Mimuro, R., Hachisuka, M., Maru, Y., Fujimoto, Y., Oka, E., Hagiwara, K. I., Imori, Y., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01728-4 · Cited by 4
Exercise Recommendations in Pediatric HCM: Variation and Influence of Provider Characteristics
Whitehill, R. D., Balaji, S., Kelleman, M. S., Chandler, S. F., Abrams, D. J., Mao, C. Y., Fischbach, P., & Campbell, R. (2021) · Pediatric Cardiology · doi:10.1007/s00246-021-02703-0 · Cited by 4
Prophylactic Implantable Defibrillators for Hypertrophic Cardiomyopathy
Grace, A. A. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003140 · Cited by 4
Maron, B. J. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.03.001 · Cited by 4
Successful launch of a comprehensive European registry for the cardiomyopathies
Keren, A., & McKenna, W. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv539 · Cited by 4
Self-citationRisk stratification in Brugada syndrome: Where is the finish line?
Postema, P. G., & Wilde, A. A. M. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.08.008 · Cited by 4
Maron, M. S., Rowin, E. J., & Maron, B. J. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.06.018 · Cited by 4
Gender disease-dose in hypertrophic cardiomyopathy
Tome, M. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.01.008 · Cited by 4
Copeland, K. M., Chen, H., Chintapula, U. K., Almasian, M., Chung, D. K., Taylor, A. M., Ding, Y., Sharma, G., Jessen, M. E., Hong, Y., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1620594 · Cited by 3
Du, Z., Wang, W., Zhao, X., Li, C., Yu, R., Liu, N., Li, S., Liu, X., Guo, X., Zuo, S., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.07.027 · Cited by 3
Hypertrophic Cardiomyopathy: Current Perspectives
Patel, D., Bhargav, R., Mousa, A., & Bokhari, S. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm42824 · Cited by 3
Wang, J., Shen, T., & Wang, S. (2025) · Medicine · doi:10.1097/md.0000000000044966 · Cited by 3
Extended ECG Monitoring in Patients with Hypertrophic Cardiomyopathy: The Tempo-HCM Study
Caro‐Codón, J., Castrejón‐Castrejón, S., Cádenas, R., Casanova, C., Vélez, A., Elorz, M. B., Lacuey, G., Climent, V. E., Salvador, O., Sánchez, A. S., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207432 · Cited by 3
Ruscio, E., Scacciavillani, R., Gurgoglione, F. L., Pinnacchio, G., Bencardino, G., Perna, F., Narducci, M. L., Pelargonio, G., Niccoli, G., Locorotondo, G., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13112626 · Cited by 3
A New Era in the Management of Hypertrophic Cardiomyopathy
Asensio, A. P., Llamas-Gómez, H., Lara-Palomo, A., Villar-Ruiz, A., Jiménez-Méndez, C., & Doza, J. A. P. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm44503 · Cited by 4
Couto, J., & Martins, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144706 · Cited by 3
Derda, A. A., Abelmann, M., Sieweke, J., Waleczek, F. J. G., Weber, N., Zehrfeld, N., Bär, C., Duncker, D., Bavendiek, U., Berliner, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54153-2 · Cited by 3
Prediction and decision-making based on nonlinear risks model in stomach cancer treatment
Красько, О. В., Reutovich, M. Y., & Ivanov, A. V. (2024) · Informatics · doi:10.37661/1816-0301-2024-21-1-65-82 · Cited by 3
Qian, Y., Shi, R., Zheng, J., Chen, B.-H., An, D.-A., Zhou, Y., Xiang, J., Wu, R., Zhao, L., & Wu, L.-M. (2024) · Clinical Radiology · doi:10.1016/j.crad.2024.09.022 · Cited by 3
Wang, M., Zhao, H., Wang, Z., Chen, H., Xu, X., Zheng, S., Yao, Y., & Li, J. (2024) · Diagnostics · doi:10.3390/diagnostics14202291 · Cited by 3
Hasana, U., Korpal, M., Haider, F., Umer, M., Lwin, N. P. T., Iqbal, S., Kumar, R., Ahsan, M., Hassan, E., Ullah, W., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003326 · Cited by 3
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments
Pezzini, S., Daus, F., Galli, G., Farina, A., Fragasso, G., & Spoladore, R. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12060200 · Cited by 4
Selección de temas de actualidad en arritmias y estimulación cardiaca 2015
Peinado, R., Ruiz‐Mateas, F., Izquierdo, M., Arana‐Rueda, E., Robledo, M. J. L., Arias, M. A., Jiménez‐Jáimez, J., Rodríguez‐Mañero, M., & Chimeno, J. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.11.006 · Cited by 3
ICD-Therapie zur Primär- und Sekundärprophylaxe kongenitaler arrhythmogener Erkrankungen
Duncker, D., König, T., Hohmann, S., & Veltmann, C. (2015) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-015-0372-8 · Cited by 3
Taquiso, J. L., Obillos, S. M. O., Mojica, J. V., Abrahan, L. L., Cunanan, E. L., Aherrera, J. A. M., & Magno, J. D. A. (2017) · Cardiology Research · doi:10.14740/cr614w · Cited by 3
Risk of Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy: Time to Solve the Mystery
Norrish, G., & Kaski, J. P. (2018) · Cardiogenetics · doi:10.4081/cardiogenetics.2018.7201 · Cited by 3
Role of angiotensin‐converting enzyme insertion/deletion polymorphism in sudden cardiac arrest
Liu, A., Wang, S., Zhang, C., Sun, D., & Song, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27622 · Cited by 3
Rudenko, K. V., Lazoryshynets, V. V., Trembovetska, O. M., Nevmerzhytska, L. O., Tregubova, M., & Danchenko, P. A. (2020) · World of Medicine and Biology · doi:10.26724/2079-8334-2020-2-72-109-114 · Cited by 3
Newer risk assessment strategies in hypertrophic cardiomyopathy
Chaudhry‐Waterman, N., & Cohen, M. I. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000804 · Cited by 3
Prevention of sudden cardiac death in childhood-onset hypertrophic cardiomyopathy
Kaski, J. P., & Norrish, G. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101412 · Cited by 3
Габрусенко, С. А., Saidova, M. A., Стукалова, О. В., Муссаевна, Д. Х., & Вахтанговна, М. Н. (2020) · Kardiologiia · doi:10.18087/cardio.2020.3.n944 · Cited by 3
Asymptomatic Apical Hypertrophic Cardiomyopathy in an Elite Competitive Athlete
Huang, A. L., MacNamara, J. P., Link, M. S., Martinez, M. W., Dearani, J. A., Cannon, B. C., Levine, B. D., & Ackerman, M. J. (2022) · JACC Case Reports · doi:10.1016/j.jaccas.2022.101705 · Cited by 3
Ateş, A. H., Şener, Y. Z., Şahiner, M. L., Kaya, E. B., & Aytemir, K. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.11.022 · Cited by 3
Trancuccio, A., Kukavica, D., Sugamiele, A., Mazzanti, A., & Priori, S. G. (2023) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2023.04.004 · Cited by 3
Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies
Vidal-Pérez, R., Brandao, M., Zaher, W., Casado-Arroyo, R., Bouzas‐Mosquera, A., Fontes‐Carvalho, R., & Vázquez‐Rodríguez, J. M. (2023) · World Journal of Cardiology · doi:10.4330/wjc.v15.i10.487 · Cited by 3
Murakami, T., Sakakura, K., Jinnouchi, H., Taniguchi, Y., Tsukui, T., Hatori, M., Tamanaha, Y., Kasahara, T., Watanabe, Y., Yamamoto, K., et al. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02336-8 · Cited by 3
RETRACTED ARTICLE: A systematic review and applications of how AI evolved in healthcare
Divya, K. V., & Kannadasan, R. (2023) · Optical and Quantum Electronics · doi:10.1007/s11082-023-05798-2 · Cited by 3
RetractedAkita, K., Hasegawa, K., Fifer, M. A., Tower-Rader, A. F., Jung, J., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.01.017 · Cited by 3
The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
Chow, J., Leong, K. M. W., Shun-Shin, M. J., Jones, S., Guttmann, O. P., MOHIDDIN, S. A., Lambiase, P. D., Elliot, P. M., Ormerod, J. O. M., Koa‐Wing, M., et al. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1428709 · Cited by 3
Targeting Ventricular Arrhythmias in Non-Ischemic Patients: Advances in Diagnosis and Treatment
Stanciulescu, L. A., Dorobanţu, M., & Vatasescu, R. G. (2025) · Diagnostics · doi:10.3390/diagnostics15040420 · Cited by 3
Neurological complications of cardiomyopathies
Fonseca, A. C., Almeida, A. G., Santos, M. O., & Ferro, J. M. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00001-9 · Cited by 3
Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy
O’Mahony, C., MOHIDDIN, S. A., & Knight, C. J. (2011) · Interventional Cardiology Reviews Research Resources · doi:10.15420/articles/alcohol-septal-ablation-treatment-hypertrophic-obstructive-cardiomyopathy · Cited by 3
Self-citationMirelis, J. G., Sánchez‐Gonzalez, J., Zorio, E., Ripoll‐Vera, T., Bodes, R. S., Rama, D. F., González-López, E., Gallego‐Delgado, M., Fernández‐Jiménez, R., Roncero, M. J. S., et al. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.01.026 · Cited by 3
Synkope bei hypertropher (obstruktiver) Kardiomyopathie
Seggewiß, H., Batzner, A., Seggewiss, K., & Meesmann, M. (2018) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-018-0567-x · Cited by 3
Reis, L., Teixeira, R. P., Fernandes, A. S., Almeida, I., Madeira, M., Silva, J., Botelho, A., Pais, J., Nascimento, J. H. M., & Gonçalves, L. M. M. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180099 · Cited by 3
Hypertrophic Cardiomyopathy in Adolescence
Kantor, P. F., Casarez, T. W., & Bar‐Cohen, Y. (2020) · JACC Case Reports · doi:10.1016/j.jaccas.2020.11.006 · Cited by 3
Peng, L. T., Newman, D. B., & Geske, J. B. (2020) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa450 · Cited by 3
Potratz, M., Fox, H., Rudolph, V., Faber, L., Dumitrescu, D., & Bitter, T. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.02.077 · Cited by 3
Zaidi, A., & Shah, P. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00010-1 · Cited by 3
Choi, Y., Kim, B., Lee, H., Lee, H., Park, J., Lee, S., Han, K., Kim, Y.-J., & Kim, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-07463-2 · Cited by 3
Colan, S. D., & Margossian, R. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802393-8.00019-3 · Cited by 3
The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy
Özyılmaz, S., Akgül, Ö., Uyarel, H., Püşüroğlu, H., Gül, M., Satılmışoğlu, M. H., Bolat, İ., Özyılmaz, İ., Uçar, H., Yildirim, A., et al. (2017) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2016.09.009 · Cited by 3
The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results
Cardim, N. M., Brito, D. A., Lopes, L. R., Freitas, A., Araújo, C., Belo, A., Gonçalves, L. M. M., Mimoso, J., Olivotto, I., Elliot, P. M., et al. (2018) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2018.02.008 · Cited by 3
Electroconvulsive therapy in a patient with hypertrophic cardiomyopathy: A case report
Kufner, M., Nothdurfter, C., Steffling, D., Baessler, A., Maier, L. S., & Qamar, Y. (2022) · Clinical Case Reports · doi:10.1002/ccr3.6286 · Cited by 3
Clinical genetics of dilated cardiomyopathy: on the way to personalized medicine?
Pankuweit, S., & Richter, A. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu402 · Cited by 3
The New European Society of Cardiology guidelines on hypertrophic cardiomyopathy
Elliot, P. M. (2015) · Heart · doi:10.1136/heartjnl-2014-306776 · Cited by 3
Gati, S., Drezner, J. A., & Sharma, S. (2020) · Heart · doi:10.1136/heartjnl-2020-318179 · Cited by 3
Time-Dependent ECG-AI Prediction of Fatal Coronary Heart DiseasePreprint
Butler, L., Ivanov, A., Celık, T., Karabayir, İ., Chinthala, L. K., Tootooni, M. S., Jaeger, B. C., Doerr, A., McManus, D. D., Davis, L. R., et al. (2023) · medRxiv · doi:10.1101/2023.10.11.23296910 · Cited by 3
Hypertrophic Cardiomyopathy: Evolution to the Present, Ongoing Challenges, and Opportunities
McKenna, W. J., Crean, A. M., Greenway, S. C., Tadros, R., Veselka, J., & Woo, A. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.005 · Cited by 3
Self-citationKaya, E., Otten, M., Theuns, D. A. M. J., Veen, K. M., Yap, S., Schinkel, A. F. L., Constantinescu, A. A., Michels, M., Manintveld, O. C., Szili‐Törok, T., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.01.011 · Cited by 2
Chung, D., Hochadel, M., Senges, J., Kleemann, T., Eckardt, L., Brachmann, J., Steinbeck, G., Larbig, R. K., Butter, C., Uher, T., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133858 · Cited by 2
Hancıoğlu, E., Özcan, S., Dönmez, E., Terzioğlu, C., Kırankaya, A., Tenekecigil, A., Okuyan, E., & Şahin, İ. (2025) · Biomarkers in Medicine · doi:10.1080/17520363.2025.2473304 · Cited by 2
Blázquez, M. L., Espinosa, M. Á., García-Rovés, R. Á., Jiménez, M. C., Fernández, A. I., Thomas, F. J. B., & Medrano, C. (2025) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2025.503814 · Cited by 2
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy
Bonanni, F., Franco, A. D., Setti, V., Casini, M., Salvi, S., Panichella, G., Garofalo, M., Barbagallo, A., Crucinio, I., Gozzini, A., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101730 · Cited by 2
Zhen, Z., Xu, Y., Chen, X., Jia, N., Xiao, Y., & Yuan, Y. Y. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1628585 · Cited by 2
Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan
Samarraie, A. A., Petzl, A. M., Cadrin‐Tourigny, J., & Tadros, R. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.07.002 · Cited by 2
Kim, H.-Y., Song, M. J., Kim, J., & Kim, S. M. (2025) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-025-03568-7 · Cited by 2
Effect of mavacamten on sudden cardiac death risk scores in obstructive hypertrophic cardiomyopathy
Usai, P., Cariou, E., Donal, E., Eyharts, D., Cohen, N., Lucas, C. H., Wazzan, A. A., Cherbi, M., Itier, R., Fournier, P., et al. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag003 · Cited by 2
Genotype and Family History as Risk Markers of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Sakhnini, A., Montazeri, M., Chow, C., Silver, J., Signorile, M., Chan, R. H. M., Gollob, M. H., Runeckles, K., Fan, C.-P. S., Rowin, E. J., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.01.033 · Cited by 2
Genetic and Clinical Characterization of a South-Brazilian Hypertrophic Cardiomyopathy Cohort
Beuren, T. M. A., Scolari, F. L., Sperb‐Ludwig, F., Ferrari, F., Rossi, A. P., Zawislak, R. B., van Tintelen, J. P., & Stein, R. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250420i · Cited by 2
Clinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms
Rowin, E. J., Lee, D. Z. J., Sherrid, M. V., Maron, B. J., Tower-Rader, A. F., Zocchi, C., Ahamed, H., Hari, A., Albano, A. J., Chacko, L., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102919 · Cited by 2
Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy
García‐Honrubia, A., Hernández‐Romero, D., Orenes‐Piñero, E., Romero‐Aniorte, A. I., Climent, V. E., García, M., Garrigos-Gomez, N., Moro, C., Valdés, M., & Marín, F. R. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12572 · Cited by 2
Prediction of Sudden Cardiac Death Using Ensemble Classifiers
El-Geneidy, A., Mukherjee, S., & Darwiche, A. (2021) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-73103-8_48 · Cited by 2
Identification of genes associated with sudden cardiac death: a network- and pathway-based approach
Wei, J., Ni, X., Dai, Y., Chen, X., Ding, S., Bao, J., & Xing, L. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-361 · Cited by 1
Talibullin, I. V., & Лебедева, Н. Б. (2022) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2022-1-183-196 · Cited by 2
Cardiomyopathies in the Clinical Practice – an Overview
Schulz, L. P., & Vischer, A. S. (2022) · Praxis · doi:10.1024/1661-8157/a003912 · Cited by 2
Metadata
- Authors
- O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
- Affiliations
- University College London (GB)
- National and Kapodistrian University of Athens (GR)
- University of Bologna (IT)
- Hospital Universitario Virgen de la Arrixaca (ES)
- University of Campania "Luigi Vanvitelli" (IT)
- University College Hospital at Westmoreland Street (GB)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-14
- Volume
- 35
- Issue
- 30
- Pages
- 2010-2020
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2119361626
- Cited by
- 1,251
- References
- 50
- Citations by year
- 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
- FWCI
- 39.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hispana (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (NF-SI-0509-10230)
- Università di Bologna
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
- MeSH terms
- Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
